Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2003
10/02/2003WO2003080806A2 Method for production of neutrophils and uses therefor
10/02/2003WO2003080805A2 Kinases and phosphatases
10/02/2003WO2003080802A2 Nucleic acid constructs and methods for producing altered seed oil compositions
10/02/2003WO2003080801A2 Adipose stromal stem cells for tissue and vascular modification
10/02/2003WO2003080798A2 Muscle cells and their use in cardiac repair
10/02/2003WO2003080676A1 Antibody against transferrin-containing immune complex, process for producing the antibody, hybridoma and immunoassay method
10/02/2003WO2003080675A2 MONOCLONAL ANTIBODY AGAINST INTERLEUKIN-13 RECEPTOR ALPHA 1 (IL-13Rα1)
10/02/2003WO2003080670A1 Antibody recognizing proliferative human liver cells, proliferative human liver cells and functional human liver cells
10/02/2003WO2003080660A2 Method for the preparation of recombinant mammalian heparin-binding protein (hbp)
10/02/2003WO2003080649A2 Induction of hepatocyte proliferation in vitro by inhibition of cell cycle inhibitors
10/02/2003WO2003080640A1 Lymphatic and blood endothelial cell genes
10/02/2003WO2003080639A1 Novel compositions and methods in cancer associated with altered expression of kcnj9
10/02/2003WO2003080638A2 Antisense iap nucleobase oligomers and uses thereof
10/02/2003WO2003080570A2 Recombinant expression vectors for functional nav1.9 sodium channels
10/02/2003WO2003080116A1 Modulating angiogenesis
10/02/2003WO2003080105A2 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof
10/02/2003WO2003079987A2 A non-selective cation channel in neural cells and methods for treating brain swelling
10/02/2003WO2003079985A2 Method and apparatus for preparing biomimetic scaffold
10/02/2003WO2003079977A2 Novel compositions and methods in cancer associated with altered expression of mcm3ap
10/02/2003WO2003079767A1 Method of transforming plant of the genus coffer
10/02/2003WO2003079757A2 Hiv therapeutic
10/02/2003WO2003079750A2 ANTAGONISTIC ANTI-hFAS LIGAND HUMAN ANTIBODIES AND FRAGMENTS THEREOF
10/02/2003WO2003079748A2 Potentiation of cancer therapies by znf217 inhibition
10/02/2003WO2003062414A3 Methods of obtaining isoform specific expression in mammalian cells
10/02/2003WO2003062394A9 Methods and compositions for rna interference
10/02/2003WO2003057862A3 Transdifferentiation of pancreatic acinar cells
10/02/2003WO2003035694A3 Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof
10/02/2003WO2003033534A3 Ngzipa, ngzipd, pgzipa, and pgzipd polynucleotides and polypeptides and uses thereof
10/02/2003WO2003020938A3 Method of protein production in plants
10/02/2003WO2003016535A3 Novel amylases and uses thereof
10/02/2003WO2003014314A3 13 human secreted proteins
10/02/2003WO2003009743A3 Hypertonic reduction of chilling injury
10/02/2003WO2003006950A3 Cells of the cardiomyocyte lineage produced from human pluripotent stem cells
10/02/2003WO2003006493A3 Histidine phosphatase interacting protein with 180kd
10/02/2003WO2003004655A3 Use of the cd24 marker gene for the selection of keratinocyte stem cells transformed by exogenous sequences
10/02/2003WO2002099056A3 C22c7orfs as modifiers of the p53 pathway and methods of use
10/02/2003WO2002092759A3 Molecules for disease detection and treatment
10/02/2003WO2002090382A3 Mixture of peptides derived from e6 and/or e7 papillomavirus proteins and uses thereof
10/02/2003WO2002083160A3 Agents, which inhibit apoptosis in cells that are involved in wound healing
10/02/2003WO2002080852A3 Genes expressed in intestinal epithelium and peyer's patch m cells
10/02/2003WO2002079239A3 Chimeric filovirus glycoprotein
10/02/2003WO2002070737A9 Compositions and methods relating to osteoarthritis
10/02/2003WO2002068597A3 Enzymes having alpha amylase activity and methods of use thereof
10/02/2003WO2002064158A3 Use of a conjugate of il-6 and the receptor thereof for inducing cellular expression of scf and flt-3l
10/02/2003WO2002042432A3 Epothilone resistant cell lines
10/02/2003WO2002036748A3 Methods for depleting and isolating alloreactive and antigen-reactive t cells from hematopoietic donor cells
10/02/2003WO2002022809A3 PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST
10/02/2003WO2002008383A3 Sp110, a polypeptide component of the nuclear body
10/02/2003WO2002002623A3 Compositions and methods for the therapy and diagnosis of lung cancer
10/02/2003WO2001098508A3 Transgenic mice containing targeted gene disruptions
10/02/2003WO2001098491A3 Osteolevin gene polymorphisms
10/02/2003WO2001090155A3 Novx proteins and nucleic acids encoding same. diagnostic and therapeutic uses
10/02/2003WO2001086307A3 Compositions and methods for the diagnosis, treatment and prevention of steroid hormone responsive cancers
10/02/2003US20030188337 Transgenic plants
10/02/2003US20030188336 Trangenic plant coding insecticidal protein for use in biological pest control; disease resistant plants
10/02/2003US20030188329 Genetic construct comprising a conditionally lethal gene operably associated with promoter functional in plant cell, gene being used to select, identify or selectively kill a plant expressing said gene
10/02/2003US20030188325 Genetically engineered rodent cells comprising mutated regulatory erythroid kinase (REDK) gene for treatment of blood disorders such as anemia; animal models
10/02/2003US20030187515 Dry decellularized amniotic membrane capable of being stored at room temperature and subsequent to rehydration can be used for a variety of medical and/or research purposes
10/02/2003US20030187245 Comprises expression vectors coding proteins for regulation and expression of transgenes and treatment of allergies, inflammation, arthritis and nervous system disorders; gene therapy; antiproliferative agents
10/02/2003US20030187242 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030187239 Comprises nucleotide sequences coding membrane proteins for use as antiproliferative/antitumor/antiinflammatory agents; drug screening
10/02/2003US20030187238 Comprises nucleotide sequences coding membrane proteins for use as antiproliferative/antitumor/antiinflammatory agents; drug screening
10/02/2003US20030187230 Chimeric humanized monoclonal antibody for treating tumors and inflammation
10/02/2003US20030187229 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030187228 Chimeric humanized monoclonal antibody for treating tumors and inflammation
10/02/2003US20030187224 Chimeric OPG polypeptides
10/02/2003US20030187218 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes by contacting blood with pro-polypeptides; cancer diagnosis
10/02/2003US20030187215 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes by contacting blood with pro-polypeptides; cancer diagnosis
10/02/2003US20030187214 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030187212 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030187206 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030187200 Comprises nucleotide sequences coding kunitz-type protease inhibitor for treating reproductive, hemostatic and inflammatory disorders
10/02/2003US20030187197 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030187196 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030187195 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030187194 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030187193 Comprises nucleotide sequences coding membrane protein for use as antitumor/anticarcinogenic/antiinflammatory/antiproliferative agents
10/02/2003US20030187192 Comprises nucleotide sequences coding membrane protein for use as antitumor/anticarcinogenic/antiinflammatory/antiproliferative agents
10/02/2003US20030187191 Comprises nucleotide sequences coding membrane protein for use as antitumor/anticarcinogenic/antiinflammatory/antiproliferative agents
10/02/2003US20030187190 Comprises nucleotide sequences coding membrane protein for use as antitumor/anticarcinogenic/antiinflammatory/antiproliferative agents
10/02/2003US20030187189 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030186920 Target genes and mRNAs encoding mammalian vascular endothelial growth factor(VEGF) receptors can be used to reduce VEGF-induced inflammation and angiogenesis; for treatmment of tumor growth and metastasis, ocular diseases, arthritis
10/02/2003US20030186905 Cis-acting regulatory nucleic acid sequences in the parathyroid hormone3' -untranslated region
10/02/2003US20030186904 Keratinocyte growth factor-2
10/02/2003US20030186903 Antisense modulation of MyD88 expression
10/02/2003US20030186902 Use of a pituitary tumor transforming gene peptide which has the ability to regulate endogenous PTTG1 expression and/or function in a dominant negative manner
10/02/2003US20030186891 Polypeptide comprising fragments of matrix extracellular phosphoglycoproteins used to control calcitriol concentrations in cells, for prophylaxis of bone disorders
10/02/2003US20030186881 Nucleotide sequences comprising complementary DNA codes for cyclin-dependent kinases, that control phosphorylation in cells, used in diagnosis and prophylaxis of diseases
10/02/2003US20030186875 Uses of mammalian cytokine; related reagents
10/02/2003US20030186866 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
10/02/2003US20030186863 For production of peptidomimetic drugs that modulate a large class of proteins involved in signal transduction pathways and oncogenesis
10/02/2003US20030186841 Ligand activated transcriptional regulator proteins
10/02/2003US20030186441 Methods for isolating novel antimicrobial agents from hypermutable mammalian cells
10/02/2003US20030186440 Preparing cellular adjuvant for treatment of neoplastic and infectious diseases; immunotherapy; antitumor agents
10/02/2003US20030186439 Cloned totipotent hepatic cells for treating diseases of the digestive system; tissue engineering
10/02/2003US20030186438 Premature osteoblast cell line derived from the peritoneum of bone for use as models for prevention and treatment of osteoporosis
10/02/2003US20030186437 Controlling enrichment for stem or progenitor cells by modulating expression of RIP-associated ICH-1 homologous protein with a death domain (RAIDD)
10/02/2003US20030186436 Insulin-secreting cell which codes and expresses glucagon-like peptides-1 (GLP-1) for treating diabetes and autoimmune diseases
10/02/2003US20030186434 Method of forming vertebrate pancreas in vitro
10/02/2003US20030186432 In vitro culture of amoebocytes from Tachypleus gigas in Leibovitz culture medium
1 ... 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 ... 1827